New York State Common Retirement Fund lowered its position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 3.6% during the fourth quarter, Holdings Channel.com reports. The fund owned ...

Tarsus Pharmaceuticals Inc (NASDAQ:TARS) is set to release its Q4 2024 earnings on Feb 25, 2025. The consensus estimate for ...

Tarsus Pharmaceuticals Inc (TARS) reports robust sales and strategic advancements, despite high operating expenses and market ...

The current price of TARS AI (TAI) is $0.114479, as of Feb 27, 2025. Over the last 24 hours, the price has moved by -7.66%, with a change of 1.19% in the past hour. For longer-term performance, the ...

Good morning, and welcome to Tarsus Year End 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to David Nakasone, ...

Q4 2024 Earnings Call Transcript February 25, 2025 Tarsus Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities research analysts at William Blair lowered their Q1 2025 earnings per share estimates for Tarsus Pharmaceuticals in a report ...

TARS Project Management, a leading firm specialising in project management and digital transformation, has increased its stake in UMB Bank to 33 per cent, reinforcing its commitment to expanding ...

Securities.io is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Trading involves risk which ...